Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452

European Journal of Heart Failure

Volumn 10, Issue 9, 2008, Pages 917-920

  Coletta, Alison P ^a   Cleland, John G F ^a   Cullington, Damien ^a   Clark, Andrew L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Heart failure; Randomised controlled trials

Indexed keywords

AMIODARONE; CK 1827452; DIURETIC AGENT; DRONEDARONE; INOTROPIC AGENT; LOOP DIURETIC AGENT; NITRATE; PLACEBO; UNCLASSIFIED DRUG;

ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; HEART SURGERY; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVASCULARIZATION; SIDE EFFECT; SWEATING; SYSTOLIC DYSFUNCTION; TACHYCARDIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CARDIOTONIC AGENTS; CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS;

EID: 51549103844     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.07.006     Document Type: Article

References (19)

1. Cleland J.G.F., Coletta A.P., Abdellah A.T., Cullington D., Clark A.L., and Rigby A.S. Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE, and stem cell therapy. Eur J Heart Fail 10 (2008) 102-108
2. Deedwania P.C., et al., for the Department of Veterans Affairs CHF-STAT Investigators. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 98 (1998) 2574-2579
3. Pedersen O.D., et al., for the Danish Investigators of Arrhythmia and Mortality ON Dofetilide study group. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. The Danish Investigators of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy. Circulation 104 (2001) 292-296
4. Kober L., et al., for the Dronedarone Study Group. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 358 (2008) 2678-2687
5. Bramah N.S., et al., for the EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357 (2007) 987-999
6. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomised controlled trial. JAMA 287 (2002) 1531-1540
7. Konstam M.A., Gheorghiade M., Burnett J.C., et al. Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297 (2007) 1319-1331
8. Pang P.S., Cleland J.G., Teerlink J.R., et al. Acute heart failure syndromes international working group. A proposal to standardise dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29 (2008) 816-824
9. Jaarsma T., van der Wal M.H., Lesman-Leegte I., et al. Coordinating study evaluating outcomes of advising and counselling in heart failure (COACH) investigators. Effects of moderate or intensive disease management program on outcome in patients with heart failure: coordinating study evaluating outcomes of advising and counselling in heart failure (COACH). Arch Intern Med 168 (2008) 316-324
10. Clark R.A., Inglis S.C., McAlister F.A., Cleland J.G.F., and Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. Br Med J (2007) 334
11. Roccaforte R., Demers C., Baldasserre F., Teo K.K., and Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 7 (2005) 1133-1144
12. Phillips C.O., Singa R.M., Rubin H.R., and Jaarsma T. Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis. Eur J Heart Fail 7 (2005) 333-341
13. Cleland J.G., et al., TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk or recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45 (2005) 1654-1664
14. Cleland J.G., et al., COMET Investigators. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the carvedilol or metoprolol European trial (COMET). J Am Coll Cardiol 47 (2006) 1603-1611
15. Cleland J.G.F., Freemantle N., Ball S.G., et al. The heart failure revascularisation trial (HEART): rationale, design and methodology. Eur J Heart Fail 5 (2003) 295-303
16. Velazquez E.J., et al., STICH investigators. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 134 (2007) 1540-1547
17. Shen Y.T., Vatner S.F., Morgans D.J., and Malik F. Activating cardiac myosin, a novel inotropic mechanism to improve cardiac function in conscious dogs with congestive heart failure. J Card Fail 12 (2006) abstract 281
18. Anderson R.L., Sueoka S.H., Lee K.H., et al. In vitro and in-vivo characterisation of CK-1827452, a selective cardiac myosin activator. J Card Fail 12 (2006) abstract 277
19. Cleland J.G.F., Coletta A.P., and Clark A.L. Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF. Eur J Heart Fail 8 (2006) 764-766